Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-25-001861

Director sold 13,333 shares at $3.77 ($50,291)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Sale : show line 1 in the form −13,333 $3.77 $50,291 683,721 D
Open-market sales · 13,333 sh · avg $3.77 · $50,291
Loading xslF345X05/ownership.xml…